In8Bio (INAB) Selling, General & Administrative (2020 - 2026)
In8Bio (INAB) recorded Selling, General & Administrative of $2.44 million in Q2 2026, down 10.0% from $2.71 million a year earlier and down 8.0% from the prior quarter.
Powered by 
Analysis
In8Bio (INAB) Selling, General & Administrative (2020 - 2026) Analysis & Trends
On a TTM basis, In8Bio's Selling, General & Administrative came in at $9.34 million as of Jun 30, 2026, down 13.2% year-over-year; for FY2025, it came in at $9.65 million, down 23.6% from FY2024.
- Annual Selling, General & Administrative has declined for three straight years, though with a five-year compound annual growth rate of 24.9% (FY2020 to FY2025).
- Across earlier years, Selling, General & Administrative came in at $12.64 million in FY2024 (-6.5%), $13.51 million in FY2023 (-6.6%), $14.46 million in FY2022 (+97.9%) and $7.31 million in FY2021 (+129.8%).
- Quarterly Selling, General & Administrative has ranged from $1.86 million in Q3 2025 to $3.88 million in Q4 2022 over the past five years.
- On a year-over-year basis, Selling, General & Administrative has declined for nine consecutive quarters, with an average decline of 17.2% over the last eight quarters.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 282.8% in Q4 2021, against a decline of 31.8% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.65 million (Q1 2026), $2.39 million (Q4 2025) and $1.86 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | In8Bio | 27.25 Mn | 27.25 Mn | - | 2.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.44 Mn |
| Mar 31, 2026 | 2.65 Mn |
| Dec 31, 2025 | 2.39 Mn |
| Sep 30, 2025 | 1.86 Mn |
| Jun 30, 2025 | 2.71 Mn |
| Mar 31, 2025 | 2.69 Mn |
| Dec 31, 2024 | 2.63 Mn |
| Sep 30, 2024 | 2.73 Mn |
| Jun 30, 2024 | 3.53 Mn |
| Mar 31, 2024 | 3.74 Mn |
| Dec 31, 2023 | 3.08 Mn |
| Sep 30, 2023 | 3.38 Mn |
| Jun 30, 2023 | 3.58 Mn |
| Mar 31, 2023 | 3.47 Mn |
| Dec 31, 2022 | 3.88 Mn |
| Sep 30, 2022 | 3.14 Mn |
| Jun 30, 2022 | 3.68 Mn |
| Mar 31, 2022 | 3.76 Mn |
| Dec 31, 2021 | 3.16 Mn |
| Sep 30, 2021 | 2.04 Mn |
API Access
In8Bio Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=INAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "INAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=INAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();